Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Prev Biotech was a Canadian health technology company formed to commercialize Smart-e-Pants, an electrical stimulation undergarment designed to help prevent pressure ulcers in people with impaired mobility or sensation, including patients with spinal cord injury or stroke. The company appears to have operated as a subsidiary of BioMotion Limited and was based in Edmonton, Alberta. Its core product used intermittent electrical stimulation of pressure-loaded gluteal muscles to mimic natural fidgeting and reduce prolonged tissue compression associated with bedsores. Publicly available evidence points to an early-stage commercialization effort centered on a single medical device program rather than a broad therapeutics pipeline. Corporate registry data indicate the entity was struck off in 2018, suggesting it is no longer active as an operating company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Prev Biotech.